[MigVax in NoCamels] Israel’s MigVax receives $4.3M award for development of oral vaccine

Source Node: 1441387

Israel’s MigVax, the affiliate company established by Israeli scientists at the Migal Galilee Research Institute to develop a vaccine for the coronavirus, has received a $4.3 million award from Norway’s Coalition of Epidemic Preparedness Innovations (CEPI) to help support the initial development of its COVID-19 oral subunit vaccine tablet.

Read more here.

Source: https://blog.ourcrowd.com/israels-migvax-receives-4-3m-award-for-development-of-oral-vaccine/

Time Stamp:

More from OurCrowd Blog